Zinc metabolism in the brain: Relevance to human neurodegenerative disorders

Neurobiology of Disease

Volumn 4, Issue 3-4, 1997, Pages 137-169

  Cuajungco, Math P ^a   Lees, Gordon J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Alzheimer's disease; Cerebral ischemia; Epilepsy; Metallothionein; Neurodegenerative disease; Zinc metabolism; Zinc neurotoxicity

Indexed keywords

AMYLOID BETA PROTEIN; ZINC;

BRAIN ISCHEMIA; DEGENERATIVE DISEASE; EPILEPSY; HUMAN; NERVE CELL NECROSIS; NEUROTOXICITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ZINC METABOLISM;

EID: 0030725838     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1997.0163     Document Type: Review

References (398)

1. Aggoun-Zouaoui D., Charriaut-Marlangue C., Rivera S., Jorquera I., Ben-Ari Y., Represa A. The HIV-1 envelope protein gp120 induces neuronal apoptosis in hippocampal slices. NeuroReport. 7:1996;433-436.
2. Allore R., O'Hanlon D., Price R., Neilson K., Willard H. F., Cox D. R., Marks A., Dunn J. N. Gene encoding the β subunit of S-100 protein is on chromosome 21: Implications for Down syndrome. Science. 239:1988;1311-1313.
3. Ancsin J. B., Kisilevsky R. Laminin interactions important for basement membrane assembly are promoted by zinc and implicate laminin zinc finger-like sequences. J. Biol. Chem. 271:1996;6845-6851.
4. Anderegg G., Hubmann E., Podder N. G., Wenk F. Pyridine derivatives as complexing agents XI: Thermodynamics of metal complex formation with bis-, tris-, and tetrakis[(2-pyridyl)methyl]-amines. Helv. Chim. Acta. 60:1977;123-140.
5. Andrasi E., Farkas E., Scheibler H., Reffy A., Bezur L. Al, Zn, Cu, Mn and Fe levels in brain in Alzheimer's disease. Arch. Gerontol. Geriatr. 21:1995;89-97.
6. Aniksztejn L., Charton G., Ben-Ari Y. Selective release of endogenous zinc from the hippocampal mossy fibersin situ. Brain Res. 404:1987;58-64.
7. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., Nicotera P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
8. 2+. J. Biol. Chem. 260:1985;2719-2727.
9. Ashall F., Goate A. M. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biochem. Sci. 19:1994;42-46.
10. 2+. Nature. 308:1984;734-736.
11. Atar D., Backx P. H., Appel M. M., Gao W. D., Marban E. Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels. J. Biol. Chem. 270:1995;2473-2477.
12. Azmitia E. C., Dolan K., Whitaker-Azmitia P. M. S-100β but not NGF, EGF, insulin, or calmodulin is a CNS serotonergic growth factor. Brain Res. 516:1990;354-356.
13. 2+2+. Brain Res. 557:1991;103-108.
14. Baba A., Kihara T., Sawada T., Iwata H. Excitatory amino acids enhance dissociation of zinc from soluble protein in cytosol of rat hippocampus. Brain Res. 486:1989;372-375.
15. Babb T. L., Kupfer W. R., Pretorius J. K., Crandall P. H., Levesque M. F. Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience. 42:1991;351-363.
16. Backstrom J. R., Lim G. P., Cullen M. J., Tokes Z. A. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40). J. Neurosci. 16:1996;7910-7919.
17. Backstrom J. R., Miller C. A., Tokes Z. A. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: Identification of calcium-dependent metalloproteinases from the hippocampus. J. Neurochem. 58:1992;983-992.
18. Baeuerle P. A. The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim. Biophys. Acta. 1072:1991;63-80.
19. Bagetta G., Corasaniti M. T., Aloe L., Berliocchi L., Costa N., Finazzi-Agro A., Nistico G. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. Natl. Acad. Sci. USA. 93:1996;928-933.
20. Ball M. J. Hippocampal histopathology - A critical substrate for dementia of the Alzheimer type. Interdisciplinary Topics in Gerontology: Histology and Histopathology of the Aging Brain. 1988;Karger, Basel. p. 16-37.
21. Banerjee A., Roychowdhury S., Bhattacharyya B. Zinc-induced self-assembly of goat brain tubulin: Some novel aspects. Biochem. Biophys. Res. Commun. 105:1982;1503-1510.
22. Baramova E., Foidart J. M. Matrix metalloproteinase family. Cell Biol. Int. 19:1995;239-242.
23. Barbieri D., Troiano L., Grassilli E., Agnesini C., Cristofalo E. A., Monti D., Capri M., Cossarizza A., Franceschi C. Inhibition of apoptosis by zinc: A reappraisal. Biochem. Biophys. Res. Commun. 187:1992;1256-1261.
24. Barger S. W., Van Eldik L. J. S-100β stimulates calcium fluxes in glial and neuronal cells. J. Biol. Chem. 267:1992;9689-9694.
25. Barker J. E., Heales S. J. R., Cassidy A., Bolanos J. P., Land J. M., Clark J. B. Depletion of brain glutathione results in a decrease of glutathione reductase activity, an enzyme susceptible to oxidative damage. Brain Res. 716:1996;118-122.
26. Basun H., Forssell L. G., Wetterberg L., Winbald B. Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease. J. Neural Transm. Parkinson's Dis. Dementia Sect. 4:1991;231-258.
27. Baudier J., Gerard D. Ions binding to S-100 proteins: Structural changes induced by calcium and zinc on S-100α and S-100β proteins. Biochem. 22:1983;3360-3369.
28. Baudier J., Haglid K., Haiech J., Gerard D. Zinc ion binding to human brain calcium-binding proteins calmodulin and S-100β protein. Biochem. Biophys. Res. Commun. 114:1983;1138-1146.
29. Beaulieu C., Dyck R., Cynader M. Enrichment of glutamate in zinc-containing terminals of the cat visual cortex. NeuroReport. 3:1992;861-864.
30. Behl C., Davis D. R., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
31. Beilharz E. J., Williams C. E., Dragunow M., Sirimanne E. S., Gluckman P. D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: Evidence for apoptosis during selective neuronal loss. Mol. Brain Res. 29:1995;1-14.
32. Ben-Shachar D., Riederer P., Youdim M. B. H. Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease. J. Neurochem. 57:1991;1609-1614.
33. Bergamaschi S., Binetti G., Govoni S., Wetsel W. C., Battaini F., Trabucchi M., Bianchetti A., Racchi M. Defective phorbol ester-stimulated secretion of β-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci. Lett. 201:1995;1-4.
34. Bettger W. J., O'Dell B. L. A critical physiological role of zinc in the structure and function of biomembrane. Life Sci. 28:1981;1425-1438.
35. Blair-West J. R., Denton D. A., Gibson A. P., McKinely M. J. Opening the blood-brain barrier to zinc. Brain Res. 507:1990;6-10.
36. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S. A. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults withND. Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
37. Bramham C. R., Torp R., Zhang N., Storm-Mathisen J., Ottersen O. P. Distribution of glutamate-like immunoreactivity in excitatory hippocampal pathways: A semiquantitative electron microscopic study in rats. Neuroscience. 39:1990;405-417.
38. Bray T. M., Bettger W. J. The physiological role of zinc as an antioxidant. Free Radicals Biol. Med. 8:1990;281-291.
39. Bremner I., May P. M. Systemic interactions of zinc. Mills C. F. Zinc in Human Biology. 1989;95-108 Springer-Verlag, London.
40. Bresink I., Ebert B., Parsons C. G., Mutschler E. Zinc changes AMPA receptor properties: Results of binding studies and patch clamp recordings. Neuropharmacology. 35:1996;503-509.
41. Brewer G. J. Calmodulin, zinc, and calcium in cellular and membrane regulation: An interpretive review. Am. J. Hemat. 8:1980;231-248.
42. Brewer G. J., Aster J. C., Knutsen C. A., Kruckeberg W. C. Zinc inhibition of calmodulin: A proposed molecular mechanism of zinc action on cellular functions. Am. J. Hemat. 7:1979;53-60.
43. Browning J. D., O'Dell B. L. Zinc deficiency decreases the concentration ofND. J. Nutrition. 125:1995;2083-2089.
44. Brun A., Gustafson L., Englund E. Subcortical pathology of Alzheimer's disease. Wurtman R. J., Corkin S., Growdon J. H., Ritter-Walker E. Advances in Neurology. 1990;73-77 Raven Press, New York.
45. Buhl E. H., Otis T. S., Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science. 271:1996;369-373.
46. Bush A. I., Atwood C. S., Huang X., Moir R. D., Glabe C. G., Tanzi R. E. Abnormal homeostasis of ph and zinc: The prelude for cerebral Aβ amyloid formation? Eur. Neuropsychopharmacol. 6:1996.
47. Bush A. I., Moir R. D., Rosenkranz K. M., Tanzi R. E. Zinc and Alzheimer's disease. Science. 268:1995;1921-1923.
48. Bush A. I., Multhaup G., Moir R. D., Williamson T. G., Small D. H., Rumble B., Pollwein P., Beyreuther K., Masters C. L. A novel zinc(II) binding site modulates the function of the βA4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268:1993;16109-16112.
49. Bush A. I., Pettingel W. H., Multhaup G., Paradis M. D., Vonsattel J. P., Gusella J. F., Beyreuther K., Masters C. L., Tanzi R. E. Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science. 265:1994a;1464-1467.
50. Bush A. I., Pettingel W. H., Paradis M. D., Tanzi R. E. Modulation of Aβ adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269:1994b;12152-12158.
51. Buxbaum J. D., Koo E. H., Greengard P. Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide. Proc. Natl. Acad. Sci. USA. 90:1993;9195-9198.
52. Calissano P., Alema S., Fasella P. Interaction of S-100 protein with cations and liposomes. Biochem. 13:1974;4553-4560.
53. Cano-Gauci D. F., Sarkar B. Reversible zinc exchange between metallothionein and the estrogen receptor zinc finger. FEBS Lett. 386:1996;1-4.
54. Casanovas-Aguilar C., Christensen M. K., Reblet C., Martinez-Garcia F., Perez-Clausell J., Bueno-Lopez J. L. Callosal neurones give rise to zinc-rich boutons in the rat visual cortex. NeuroReport. 6:1995;497-500.
55. Charriaut-Marlangue C., Aggoun-Zouaoui D., Represa A., Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy, and gp120 toxicity. Trends Neurosci. 19:1996;109-114.
56. 2+in situ. Exp. Brain Res. 58:1985;202-205.
57. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1444.
58. Chesters J. K., Petrie L., Lipson K. E. Two zinc-dependent steps during G1 to S phase transition. J. Cell. Physiol. 155:1993;445-451.
59. 2+. Exp. Cell Res. 184:1989;499-508.
60. Choi D. W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
61. Choi D. W. Bench to bedside: The glutamate connection. Science. 258:1992;241-243.
62. Choi D. W., Yokoyama M., Koh J. Zinc neurotoxicity in cortical cell culture. Neuroscience. 24:1988;67-79.
63. Christensen M. K., Frederickson C. J., Danscher G. Retrograde tracing of zinc-containing neurons by selenide ions: A survey of seven selenium compounds. J. Histochem. Cytochem. 40:1992;575-579.
64. Chuah M. I., Tennet R., Jacobs I. Response of olfactory Schwann cells to intranasal zinc sulfate irrigation. J. Neurosci. Res. 42:1995;470-478.
65. 2+2+. Brain Res. 280:1983;323-334.
66. Clements A., Allsop D., Walsh D. M., Williams C. H. Aggregation and metal-binding of mutant forms of the amyloid Aβ peptide of Alzheimer's disease. J. Neurochem. 66:1996;740-747.
67. 2+. J. Neurophysiol. 73:1995;312-319.
68. 2+. Eur. J. Physiol. 424:1993;152-158.
69. Codazzi F., Racchetti G., Grohovaz F., Meldolesi J. Transduction signals induced in rat brain cortex astrocytes by the HIV-1 gp120 glycoprotein. FEBS Lett. 384:1996;135-137.
70. Cohen G. M., Sun X. M., Snowden R. T., Dinsdale D., Skilleter D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:1992;331-334.
71. Cohen J. J., Duke R. C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:1984;38-42.
72. Connor M. A., Chavkin C. Ionic zinc may function as an endogenous ligand for the haloperidol-sensitive σ2 receptor in rat brain. Mol. Pharmacol. 42:1992;471-479.
73. Constantinidis J. Alzheimer's disease: The zinc theory. L'Encephale. 16:1990;231-239.
74. Constantinidis J. The hypothesis of zinc deficiency in the pathogenesis of neurofibrillary tangles. Med. Hypo. 35:1991;319-323.
75. Corrigan F. M., Reynolds G. P., Ward N. I. Hippocampal tin, aluminum, and zinc in Alzheimer's disease. Biometals. 6:1993;149-154.
76. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
77. Cronin J., Dudek F. E. Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res. 474:1988;181-184.
78. Csermely P., Szamel M., Resch K., Somogyi J. Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J. Biol. Chem. 263:1988;6487-6490.
79. Cuajungco M. P., Lees G. J. Prevention of zinc neurotoxicityin vivoNNNN. NeuroReport. 7:1996;1301-1304.
80. Cuajungco M. P., Lees G. J. Zinc and Alzheimer's disease: Is there a direct link? Brain Res. Rev. 23:1997;219-236.
81. Danscher G. Histochemical demonstration of heavy metals: A revised version of the sulphide silver method suitable for both light and electron microscopy. Histochemistry. 71:1981;1-16.
82. Danscher G. The autometallographic zinc-sulphide method. A new approach involvingin vivo. Histochem. J. 28:1996;361-373.
83. Danscher G., Howell G., Perez-Clausell J., Hertel N. The dithizone, Timm's sulphide silver and selenium methods demonstrate a chelatable pool of zinc in CNS. Histochemistry. 83:1985;419-422.
84. Davies P., Maloney A. J. F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
85. Dawson V. L., Dawson T. M., Uhl G. R., Snyder S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 90:1993;3256-3259.
86. Deibel M. A., Ehmann W. D., Markesbery W. R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress. J. Neurol. Sci. 143:1996;137-142.
87. de Murcia G., de Murcia J. M. Poly(ADP-ribose) polymerase: A molecular nick-sensor. Trends Biochem. Sci. 19:1994;172-176.
88. Deng Q. S., Turk G. C., Brady D. R., Smith Q. R. Evaluation of brain element composition in Alzheimer's disease using inductively-coupled plasma mass spectrometry. Neurobiol. Aging. 15:1994.
89. Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P., Marsden C. D. Alterations in the levels of iron, ferritin, and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 114:1991;1953-1975.
90. Dexter D. T., Carter C. J., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C. D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:1989a;381-389.
91. Dexter D. T., Jenner P., Schapira A. H. V., Marsden C. D. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann. Neurol. 32:1992;S94-S100.
92. Dexter D. T., Wells F., Lees A. J., Agid F., Jenner P., Marsden C. D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52:1989b;1830-1836.
93. ++. Can. J. Biochem. 49:1971;1217-1224.
94. Drachman D. A., Leavitt J. Human memory and the cholinergic system. Arch. Neurol. 30:1974;113-121.
95. Dragunow M., Faull R. L. M., Lawlor P., Beilharz E. J., Singleton K., Walker E. B., Mee E. In situ. NeuroReport. 6:1995;1053-1057.
96. Dragunow M., Goulding M., Faull R. L. M., Ralph R., Mee E., Frith R. Induction ofc-fos. Exp. Neurol. 107:1990;236-248.
97. Dragunow M., Preston K. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res. Rev. 21:1995;1-28.
98. Dreixler J. C., Leonard J. P. Subunit-specific enhancement of glutamate receptor responses by zinc. Mol. Brain Res. 22:1994;144-150.
99. Dreosti I. E. Neurobiology of zinc. Mills C. F. Zinc in Human Biology. 1989;235-248 Springer-Verlag, London.
100. Duncan M. W., Marini A. M., Watters R., Kopin I. J., Markey S. P. Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional Guamanian methods. J. Neurosci. 12:1992;1523-1537.
101. Durnam D. M., Palmiter R. D. Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J. Biol. Chem. 256:1981;5712-5716.
102. Eagle G. R., Zombola R. R., Himes R. H. Tubulin-zinc interactions: Binding and polymerization studies. Biochemistry. 22:1983;221-228.
103. Ebadi M. Metallothioneins and other zinc-binding proteins in brain. Methods Enzymol. 205:1991;363-387.
104. Ebadi M., Hama Y. Zinc-binding proteins in the brain. Adv. Exp. Med. Biol. 203:1986;557-570.
105. Ebadi M., Iversen P. L., Hao R., Cerutis D. R., Rojas P., Happe H. K., Murrin L. C., Pfeiffer R. F. Expression and regulation of brain metallothionein. Neurochem. Int. 27:1995;1-22.
106. Ebadi M., Perini F., Mountjoy K., Garvey J. S. Amino acid composition, immunoreactivity, sequence analysis, and function of bovine hippocampal metallothionein isoforms. J. Neurochem. 66:1996;2121-2127.
107. Erickson J. C., Hollopeter G., Thomas S. A., Froelick G. J., Palmiter R. D. Disruption of the metallothionein-III gene in mice: Analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J. Neurosci. 17:1997;1271-1281.
108. Erickson J. C., Sewell A. K., Jensen L. T., Winge D. R., Palmiter R. D. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649:1994;297-304.
109. Esler W. P., Stimson E. R., Jennings J. M., Ghilardi J. R., Mantyh P. W., Maggio J. E. Zinc-induced aggregation of human and rat β-amyloid peptidesin vitro. J. Neurochem. 66:1996;723-732.
110. Estus S., Zaks W. J., Freeman R. S., Gruda M., Bravo R., Johnson E. M. J. Altered gene expression in neurons during programmed cell death: Identification ofc-jun. J. Cell Biol. 127:1994;1717-1727.
111. Fabris N., Mocchegiani E. Zinc, human diseases and aging. Aging Clin. Exp. Res. 7:1995;77-93.
112. Favier A., Sappey C., Leclerc P., Faure P., Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem. Biol. Inter. 91:1994;165-180.
113. Filipek A., Heizmann C. W., Kuznicki J. Calcyclin is a calcium and zinc binding protein. FEBS Lett. 264:1990;263-266.
114. 2+. NeuroReport. 4:1993;383-386.
115. Fliss H., Menard M. Hypochlorous acid-induced mobilization of zinc from metalloproteins. Arch. Biochem. Biophys. 287:1991;175-179.
116. Fliss H., Menard M. Oxidant-induced mobilization of zinc from metallothionein. Arch. Biochem. Biophys. 293:1992;195-199.
117. Fliss H., Menard M., Desai M. Hypochlorous acid mobilizes cellular zinc. Can. J. Physiol. Pharmacol. 69:1991;1686-1691.
118. Frederickson C. J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
119. Frederickson C. J., Hernandez M. D., Goik S. A., Morton J. D., McGinty J. F. Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: A histofluorescence study. Brain Res. 446:1988;383-386.
120. Frederickson C. J., Hernandez M. D., McGinty J. F. Translocation of zinc may contribute to seizure-induced death of neurons. Brain Res. 480:1989;317-321.
121. Frederickson C. J., Kasarskis E. J., Ringo D., Frederickson R. E. A quinoline fluorescence method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J. Neurosci. Methods. 20:1987a;91-103.
122. Frederickson C. J., Klitenick M. A., Manton W. I., Kirkpatrick J. B. Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat. Brain Res. 273:1983;335-339.
123. Frederickson C. J., Manton W. I., Frederickson M. H., Howell G. A., Mallory M. A. Stable-isotope dilution measurement of zinc and lead in rat hippocampus and spinal cord. Brain Res. 246:1982;338-341.
124. Frederickson C. J., Moncrieff D. W. Zinc-containing neurons. Biol. Signals. 3:1994;127-139.
125. Frederickson C. J., Perez-Clausell J., Danscher G. Zinc-containing 7S-NGF complex: Evidence from zinc histochemistry for localization in salivary secretory granules. J. Histochem. Cytochem. 35:1987b;579-583.
126. 2+. Brain Res. 654:1994;257-264.
127. Fukahori M., Itoh M., Oomagari K., Kawasaki H. Zinc content in discrete hippocampal and amygdaloid areas of the epilepsy (E1) mouse and normal mice. Brain Res. 455:1988;381-384.
128. Fuson K. S., Boggs L. N., May P. C. Zinc promotes Aβ aggregation but attenuates Aβ neurotoxicity. Neurobiol. Aging. 17:1996.
129. Gabrielsson B., Robson T., Norris D., Chung S. H. Effects of divalent metal ions on the uptake of glutamate and GABA from synaptosomal fractions. Brain Res. 384:1986;218-223.
130. Gabuzda D., Busciglio J., Yankner B. A. Inhibition of β-amyloid production by activation of protein kinase C. J. Neurochem. 61:1993;2326-2329.
131. Gajate C., Alonso M. T., Schimmang T., Mollinedo F. C-fos. Biochem. Biophys. Res. Commun. 218:1996;267-272.
132. Gaskin F., Kress Y. Zinc ion-induced assembly of tubulin. J. Biol. Chem. 252:1977;6918-6924.
133. Gaskin F., Kress Y., Brosnan C., Bornstein M. Abnormal tubulin aggregates induced by zinc sulfate in organotypic cultures of nerve tissue. Neuroscience. 3:1978;1117-1128.
134. Globus M. Y. T., Ginsberg M. D., Busto R. Excitotoxic index - A biochemical marker of selective vulnerability. Neurosci. Lett. 127:1991;39-42.
135. Goldblum S. E., Cohen D. A., Jay M., McClain C. J. Interleukin 1-induced depression of iron and zinc: Role of granulocytes and lactoferrin. Am. J. Physiol. 252:1987;E27-E32.
136. Golden B. E. Zinc in cell division and tissue growth: Physiological aspects. Mills C. F. Zinc in Human Biology. 1989;119-128 Springer-Verlag, London.
137. Gottschall P. E., Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J. Neurochem. 64:1995;1513-1520.
138. Green L. M., Berg J. M. Retroviral nucleocapsid protein-metal ion interactions: Folding and sequence variants. Proc. Natl. Acad. Sci. USA. 87:1990;6403-6407.
139. Greenlund L. J. S., Deckwerth T. L., Johnson E. M. J. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
140. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White III C. L., Araoz C. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
141. Griffin W. S. T., Yeralan O., Sheng J. G., Boop F. A., Mrak R. E., Rovnaghi C. R., Burnett B. A., Feoktistova A., Van Eldik L. J. Overexpression of the neutrophic cytokine S100β in human temporal lobe epilepsy. J. Neurochem. 65:1995;228-233.
142. Grilli M., Ribola M., Alberici A., Valerio A., Memo M., Spano P. Identification and characterization of a κB/Rel. J. Biol. Chem. 270:1995;26774-26777.
143. 1-42. J. Neurochem. 65:1995;292-300.
144. Halliwell B., Gutteridge J. M. C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219:1984;1-14.
145. 2+. Neuropharmacol. 33:1994;935-952.
146. Haug F. M. S. Electron microscopical localization of the zinc in hippocampal mossy fibre synapses by a modified sulfide silver procedure. Histochemie. 8:1967;355-368.
147. Haug F. M. S., Blackstad T. W., Simonsen A. H., Zimmer J. Timm's sulfide silver reaction for zinc during experimental anterograde degeneration of hippocampal mossy fibers. J. Comp. Neurol. 142:1971;23-32.
148. Hedberg K. K., Birrell G. B., Mobley P. L., Griffith O. H. Transition metal chelator TPEN counteracts phorbol ester-induced actin cytoskeletal disruption in c6 rat glioma cells without inhibiting activation or translocation of protein kinase C. J. Cell. Physiol. 158:1994;337-346.
149. Heizmann C. W., Braun K. Calcium Regulation by Calcium-Binding Proteins in Neurodegenerative Disorders. 1995;Springer-Verlag/Landes, Austin.
150. Hendriks L., Van Broeckhoven C. The βA4 amyloid precursor protein gene and Alzheimer's disease. Eur. J. Biochem. 237:1996;6-15.
151. Herdegen T., Kovary K., Buhl A., Bravo R., Zimmermann M., Gass P. Basal expression of the inducible transcription factorsc-jun, JunB, JunD, c-Fos, FosB,krox-24. J. Comp. Neurol. 354:1995;39-56.
152. Hesse G. Chronic zinc deficiency alters neuronal function of hippocampal mossy fibers. Science. 205:1979;1005-1007.
153. Hexum T. D. Studies on the reaction catalyzed by transport (Na,K) adenosine triphosphatease-I: Effects of divalent metals. Biochem. Pharmacol. 23:1974;3441-3447.
154. Hirsch E. C. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease. Ann. Neurol. 32:1992;S88-S93.
155. Holland D. R., Cousens L. S., Meng W., Matthews B. W. Nerve growth factor in different crystal forms displays structural flexibility and reveals zinc binding sites. J. Mol. Biol. 239:1994;385-400.
156. Hopkins S. J., Rothwell N. J. Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci. 18:1995;83-88.
157. Howell G. A., Frederickson C. J. A retrograde transport method for mapping zinc-containing fiber systems in the brain. Brain Res. 515:1989;277-286.
158. Howell G. A., Welch M. G., Frederickson C. J. Stimulation-induced uptake and release of zinc in hippocampal slices. Nature. 308:1984;736-738.
159. Huang K. P. The mechanism of protein kinase C activation. Trends Neurosci. 12:1989;425-432.
160. Huang J., Philbert M. A. Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res. 680:1995;16-22.
161. Hubbard S. R., Bishop W. R., Kirschmeier P., George S. J., Cramer S. P., Hendrickson W. A. Identification and characterization of zinc binding sites in protein kinase C. Science. 254:1991;1776-1779.
162. Hung A. Y., Haass C., Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H., Selkoe D. J. Activation of protein kinase C inhibits cellular production of the amyloid-β protein. J. Biol. Chem. 268:1993;22959-22962.
163. Hunter F. E. J., Ford L. Inactivation of oxidative and phosphorylative systems in mitochondria by preincubation with phosphate and other ions. J. Biol. Chem. 216:1955;357-369.
164. Hutchin T., Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 92:1995;6892-6895.
165. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 459:1988;138-144.
166. Israel N., Hazan U., Alcami J., Munier A., Arenzana-Seisdedos F., Bachelerie F., Israel A., Virelizier J. L. Tumor necrosis factor stimulates transcription of HIV-1 in human t lymphocytes, independently and synergistically with mitogens. J. Immunol. 143:1989;3956-3960.
167. Itoh M., Ebadi M., Swanson S. The presence of zinc-binding proteins in brain. J. Neurochem. 41:1983;823-829.
168. Iversen L. L., Mortishire-Smith R. J., Pollack S. J., Shearman M. S. The toxicityin vitro. Biochem. J. 311:1995;1-16.
169. Izumi R., Yamada T., Yoshikai S. I., Hattori M., Sakaki Y. Positive and negative regulatory elements for the expression of the Alzheimer's disease amyloid precursor-encoding gene in mouse. Gene. 112:1992;189-195.
170. Jenner P. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol. Scand. Suppl. 146:1993;6-13.
171. Jenner P., Dexter D. T., Sian J., Schapira A. H. V., Marsden C. D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32:1992;S82-S87.
172. 2+2+. Lab. Invest. 73:1995;111-117.
173. Kagi J. H. R., Schaffer A. Biochemistry of metallothionein. Biochem. 27:1988;8509-8515.
174. Kaiser J. Alzheimer's: Could there be a zinc link? Science. 265:1994;1365.
175. Kamizono A., Nishizawa M., Teranishi Y., Murata K., Kimura A. Identification of a gene conferring resistance to zinc and cadmium ions in the yeastSaccharomyces cerevisiae. Mol. Gen. Genet. 219:1989;161-167.
176. Kasarskis E. J. Zinc metabolism in normal and zinc-deficient rat brain. Exp. Neurol. 85:1984;114-127.
177. Kato K., Suzuki F., Morishita R., Asano T., Sato T. Selective increase in S-100β protein by aging in rat cerebral cortex. J. Neurochem. 54:1990;1269-1274.
178. Kelly E. J., Quaife C. J., Froelick G. J., Palmiter R. D. Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J. Nutrition. 126:1996;1782-1790.
179. Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
180. Kesslak J. P., Frederickson C. J., Gage F. H. Quantification of hippocampal noradrenaline and zinc changes after selective cell destruction. Exp. Brain Res. 67:1987;77-84.
181. Killinger S., Li Y., Balcar V. J. Sensitivity of the binding sites on glutamate transporters to neurotoxic agents. NeuroReport. 6:1995;1290-1292.
182. 2+. FEBS Lett. 20:1972;229-232.
183. Kligman D., Marshak D. R. Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. USA. 82:1985;7136-7139.
184. Koh J. Y., Choi D. W. Zinc alters excitatory amino acid neurotoxicity on cortical neurons. J. Neurosci. 8:1988;2164-2171.
185. Koh J. Y., Choi D. W. Zinc toxicity on cultured cortical neurons: involvement ofND. Neuroscience. 60:1994;1049-1057.
186. Koh J. Y., Suh S. W., Gwag B. J., He Y. Y., Hsu C. Y., Choi D. W. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 272:1996;1013-1016.
187. Koizumi S., Ikeda M., Inoue K., Nakazawa K., Inoue K. Enhancement by zinc of ATP-evoked dopamine release from rat pheochromocytoma PC12 cells. Brain Res. 673:1995;75-82.
188. Kozma M., Szerdahelyi P., Kasa P. Histochemical detection of zinc and copper in various neurons of the central nervous system. Acta Histochem. 69:1981;12-17.
189. Kress Y., Gaskin F., Brosnan C. F., Levine S. Effects of zinc on the cytoskeletal proteins in the central nervous system of the rat. Brain Res. 220:1981;139-149.
190. Krezoski S. K., Villalobos J., Shaw III C. F., Petering D. H. Kinetic lability of zinc bound to metallothionein in Erhlich cells. Biochem. J. 255:1988;483-491.
191. 2+. Trends Pharmacol. Sci. 17:1996;114-120.
192. Kudo H., Kokunai T., Kondoh T., Tamaki N., Matsumoto S. Quantitative analysis of glutathione rat central nervous system: Comparison of GSH in infant brain with that in adult brain. Brain Res. 511:1990;326-328.
193. Kumamoto E., Murata Y. Characterization of GABA current in rat septal cholinergic neurons in culture and its modulation by metal cations. J. Neurophysiol. 74:1995;2012-2027.
194. 2+. J. Neurophysiol. 76:1996;227-241.
195. A. J. Neurophysiol. 62:1994;602-607.
196. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Gen. 9:1995;21-29.
197. Laube B., Kuhse J., Rundstrom N., Kirsch J., Schmieden V., Betz H. Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors. J. Physiol. 483:1995;613-619.
198. 2+in vitro. Biochemistry. 35:1996;3837-3844.
199. Lees G. J. Inhibition of sodium-potassium ATPase: A potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Rev. 16:1991;221-228.
200. Lees G. J. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:1993;287-322.
201. Lees G. J., Lehmann A., Sandberg M., Hamberger A. The neurotoxicity of zinc in the rat hippocampus. Neurosci. Lett. 120:1990;155-158.
202. Lees G. J., Leong W. Brain lesions induced by specific and non-specific inhibitors of sodium-potassium ATPase. Brain Res. 649:1994;225-233.
203. Lees G. J., Leong W. The sodium-potassium ATPase inhibitor ouabain is neurotoxic in the rat substantia nigra and striatum. Neurosci. Lett. 188:1995;113-116.
204. Leonard J., Parrott C., Buckler-White A. J., Turner W., Ross E. K., Martin M. A., Rabson A. B. The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J. Virol. 63:1989;4919-4924.
205. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingel W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y. H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995b;973-977.
206. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A. B., Weber J. L., Bird T. D., Schellenberg G. D. A familial alzheimer's disease locus on chromosome 1. Science. 269:1995a;970-973.
207. Lim G. P., Backstrom J. R., Cullen M. J., Miller C. A., Atkinson R. D., Tokes Z. A. Matrix metalloproteinase in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J. Neurochem. 67:1996;251-259.
208. Lin Y. S., Kao S. F., Jan M. S., Cheng M. L., Wing L. Y. C., Chang W. C., Lei H. Y., Lin M. T. Changes of protein kinase C subspecies in staphylococcal enterotoxin-B-induced thymocyte apoptosis. Biochem. Biophys. Res. Commun. 213:1995;1132-1139.
209. Link T. A., von Jagow G. Zinc ions inhibit the Qp center of bovine heart mitochondrialbcl. J. Biol. Chem. 270:1995;25001-25006.
210. Long Y., Hardwick A. L., Frederickson C. J. Zinc-containing innervation of the subicular region in the rat. Neurochem. Int. 27:1995;95-103.
211. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R., Sigler P. B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:1991;497-505.
212. Lyons T. J., Liu H., Goto J. J., Nersissian A., Roe J. A., Graden J. A., Cafe C., Ellerby L. M., Bredesen D. E., Butler Gralla E., Selverstone Valentine J. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. USA. 93:1996;12240-12244.
213. Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R., Maggio J. E. Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J. Neurochem. 61:1993;1171-1174.
214. Maret W. Oxidative metal release from metallothionein via zinc-thiol/disulfide interchange. Proc. Natl. Acad. Sci. USA. 91:1994;237-241.
215. Maret W. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc. Neurochem. Int. 27:1995;111-117.
216. Marshak D. R., Pesce S. A., Stanley L. C., Griffin W. S. T. Increased S-100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging. 13:1991;1-7.
217. Martinez-Balbas M. A., Jimenez-Garcia E., Azorin F. Zinc(II) ions selectively interact with DNA sequences present at the TFIIIA binding site of theXenopous. Nucleic Acids Res. 23:1995;2464-2471.
218. Masters B. A., Quaife C. A., Erickson J. C., Kelly E. J., Froelick G. J., Zambrowicz B. P., Brinster R. L., Palmiter R. D. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 14:1994;5844-5857.
219. 2+2+. J. Neurochem. 67:1996;317-323.
220. Mattson M. P. Untangling the pathophysiochemistry of β-amyloid. Nature Struc. Biol. 2:1995a;926-928.
221. Mattson M. P. Degenerative and protective signalling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging. 16:1995b;447-463.
222. Mayer M. L., Vyklicky L. J. The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus. J. Physiol. 415:1989;351-365.
223. Mayer M. L., Vyklicky L. J., Westbrook G. L. Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones. J. Physiol. 415:1989;329-350.
224. McCabe M. J. J., Jiang S. A., Orrenius S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab. Invest. 69:1993;101-110.
225. McCord J. M., Flores S. C. The human immunodeficiency virus and oxidative balance. Paoletti R., Samuelsson B., Catapano A. L., Poli A., Rinetti M. Oxidative Processes and Antioxidants. 1994;13-23 Raven Press, New York.
226. McGeer P. L., McGeer E. G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
227. McNall A. D., Etherton T. D., Fosmire G. J. The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin-like growth factor I and growth hormone receptor genes. J. Nutrition. 125:1995;874-879.
228. Mecocci P., MacGarvey U., Beal M. F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
229. Meister A. Selective modification of glutathione metabolism. Science. 200:1983;472-477.
230. Mely Y., De Rocquigny H., Morellet N., Roques B. P., Gerard D. Zinc binding to the HIV-1 nucleocapsid protein: A thermodynamic investigation by fluorescence spectroscopy. Biochem. 35:1996;5175-5182.
231. Mills C. F. The biological significance of zinc for man: Problems and prospects. Mills C. F. Zinc in Human Biology. 1989;371-381 Springer-Verlag, London.
232. Mitchell C. L., Barnes M. I. Proconvulsant action of diethyldithiocarbamate in stimulation of the perforant path. Neurotoxicol. Teratol. 15:1993;165-171.
233. Mitchell C. L., Barnes M. I., Grimes L. M. Diethyldithiocarbamate and dithizone augment the toxicity of kainic acid. Brain Res. 506:1990;327-330.
234. Mochizuki H., Goto K., Mori H., Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137:1996;120-123.
235. 2+. Trends Pharmacol. Sci. 16:1995;356-359.
236. Mody I., Miller J. J. Levels of hippocampal calcium and zinc following kindling-induced epilepsy. Can. J. Physiol. Pharmacol. 63:1985;159-161.
237. Morton J. D., Howell G. A., Frederickson C. J. Effects of subcutaneous injections of zinc chloride on seizures induced by noise and by kainic acid. Epilepsia. 31:1990;139-144.
238. Multhaup G., Bush A. I., Pollwein P., Masters C. L. Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βa4 amyloid precursor protein. FEBS Lett. 355:1994;151-154.
239. 2+2+. J. Biol. Chem. 262:1987;13902-13906.
240. Mustafa M. G., Cross C. E., Munn R. J., Hardie J. A. Effects of divalent metal ions on alveolar macrophage membrane adenosine triphosphatase activity. J. Lab. Clin. Med. 77:1971;563-571.
241. Mutisya E. M., Bowling A. C., Beal M. F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63:1994;2179-2184.
242. Narindrasorasak S., Altman R. A., Gonzales-DeWhitt P., Greenberg B. D., Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 72:1995;272-282.
243. Narindrasorasak S., Lowery D. E., Altman R. A., Gonzales-DeWhitt P. A., Greenberg B. D., Kisilevsky R. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab. Invest. 67:1992;643-652.
244. 2. Brain Res. 604:1993;298-303.
245. Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex. I. Clinical features. Ann. Neurol. 19:1986;517-524.
246. Nitatori T., Sato N., Waguri S., Karasawa Y., Araki H., Shibanai K., Kominami E., Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15:1995;1001-1011.
247. Odeh M. The role of zinc in acquired immunodeficiency syndrome. J. Internal Med. 231:1992;463-469.
248. O'Halloran T. V. Transition metals in control of gene expression. Science. 261:1993;715-725.
249. Olanow C. W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
250. Omichinski J. G., Trainor C., Evans T., Gronenborn A. M., Clore G. M., Felsenfeld G. A small single-"finger" peptide from the erythroid transcription factor GATA-1 binds specifically to DNA as a zinc or iron complex. Proc. Natl. Acad. Sci. USA. 90:1993;1676-1680.
251. Palmiter R. D. Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient. Toxicol. Appl. Pharmacol. 135:1995;139-146.
252. Palmiter R. D., Findley S. D. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 14:1995;639-649.
253. Palmiter R. D., Cole T. B., Findley S. D. ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. EMBO J. 15:1996a;1784-1791.
254. Palmiter R. D., Cole T. B., Quaife C. J., Findley S. D. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc. Natl. Acad. Sci. USA. 93:1996b;14934-14939.
255. Palmiter R. D., Findley S. D., Whitmore T. E., Durnam D. M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. USA. 89:1992;6333-6337.
256. Pattison S. E., Dunn M. F. On the mechanism of divalent metal ion chelator induced activation of the 7S nerve growth factor esteropeptidase: activation by 2,2′,2′′-terpyridine and by 8-hydroxyquinoline-5-sulfonic acid. Biochem. 15:1976a;3691-3696.
257. Pattison S. E., Dunn M. F. On the mechanism of divalent metal ion chelator induced activation of the 7S nerve growth factor esteropeptidase: Thermodynamics and kinetics of activation. Biochem. 15:1976b;3696-3703.
258. Pavletich N. P., Pabo C. O. Zinc finger-DNA recognition: Crystal structure of a Zif268-DNA complex at 2.1 angstrom. Science. 252:1991;809-817.
259. Pedrocchi M., Schafer B. W., Durussel I., Cox J. A., Heizmann C. W. Purification and characterization of the recombinant human calcium-binding S-100 proteins CAPL and CACY. Biochemistry. 33:1994;6732-6738.
260. Pei Y. Q., Koyama I. Features of seizures and behavioral changes induced by intrahippocampal injection of zinc sulfate in the rabbit: A new experimental model of epilepsy. Epilepsia. 27:1986;183-188.
261. Pei Y. Q., Zhao D., Huang J., Cao L. Zinc-induced seizures: A new experimental model of epilepsy. Epilepsia. 24:1983;169-176.
262. Peled-Kamar M., Lotem J., Okon E., Sachs L., Groner Y. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn-superoxide dismutase: Implications for Down syndrome. EMBO J. 14:1995;4985-4993.
263. Perez-Clausell J., Danscher G. Intravesicular localization of zinc in rat telencephalic boutons: A histochemical study. Brain Res. 337:1985;91-98.
264. Perez-Clausell J., Danscher G. Release of zinc sulphide accumulation into synaptic clefts afterin vivo. Brain Res. 362:1986;358-361.
265. Persechini A., McMillan K., Masters B. S. S. Inhibition of nitric oxide synthase activity by zinc ion. Biochemistry. 34:1995;15091-15095.
266. Peters S., Koh J. Y., Choi D. W. Zinc selectively blocks the action ofND. Science. 236:1987;589-593.
267. Pollard H., Cantagrel S., Charriaut-Marlangue C., Moreau J., Ben-Ari Y. Apoptosis associated DNA fragmentation in epileptic brain damage. NeuroReport. 5:1994a;1053-1055.
268. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994b;7-18.
269. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
270. Posewitz M. C., Wilcox D. E. Properties of the Sp1 zinc finger 3 peptide: Coordination chemistry, redox reactions, and metal binding competition with metallothionein. Chem. Res. Toxicol. 8:1995;1020-1028.
271. Pountney D. L., Fundel S. M., Faller P., Birchler N. E., Hunziker P., Vasak M. Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain. FEBS Lett. 345:1994;193-197.
272. Prasad A. S. Zinc: The biology and therapeutics of an ion. Ann. Int. Med. 125:1996;142-144.
273. Price R. W., Brew B., Sidtis J., Rosenblaum M., Scheck A., Cleary P. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science. 239:1988;586-592.
274. Provinciali M., Di Stefano G., Fabris N. Dose-dependent opposite effect of zinc on apoptosis in mouse thymocytes. Int. J. Immunopharmacol. 17:1995;735-744.
275. Przedborski S., Donaldson D., Jakowec M., Kish S. J., Guttman M., Rosoklija G., Hays A. P. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;158-165.
276. 65. J. Neurochem. 56:1991;485-489.
277. Quaife C. J., Findley S. D., Erickson J. C., Froelick G. J., Kelly E. J., Zambrowicz B. P., Palmiter R. D. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry. 33:1994;7250-7259.
278. Quitschke W. W. Two nuclear factor binding domains activate expression from the human amyloid β-protein precursor promoter. J. Biol. Chem. 269:1994;21229-21233.
279. Rabizadeh S., Gralla E. B., Borchelt D. R., Gwinn R., Valentine J. R., Sisodia S., Wong P., Lee M., Hahn H., Bredesen D. E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA. 92:1995;3024-3028.
280. Ratan R. R., Murphy T. H., Baraban J. M. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:1994;376-379.
281. Reeves R. H., Yao J., Crowley M. R., Buck S., Zhang X., Yarowsky P., Gearhart J. D., Hilt D. C. Astrocytosis and axonal proliferation in the hippocampus of S-100β transgenic mice. Proc. Natl. Acad. Sci. USA. 91:1994;5359-5363.
282. Reinhardt D., Mann K., Nischt R., Fox J. W., Chu M. L., Krieg T., Timpl R. Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc. J. Biol. Chem. 268:1996;10881-10887.
283. Reyes J. G. Zinc transport in mammalian cells. Am. J. Physiol. 270:1996;C401-C410.
284. Rhodes D., Klug A. Zinc fingers. Sci. Am. 268:1993;32-39.
285. A. Brain Res. 680:1995;80-87.
286. Rice W. G., Schaeffer C. A., Harten B., Villinger F., South T. L., Summers M. F., Henderson L. E., Bess J. W. J., Arthur L. O., McDougal J. S., Orloff S. L., Mendeleyev J., Kun E. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature. 361:1993;473-475.
287. Richfield E. K. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex. Mol. Pharmacol. 43:1993;100-108.
288. Rigaud-Monnet A. S., Heron A., Seylaz J., Pinard E. Effect of inhibiting NO synthesis on hippocampal extracellular glutamate concentration in seizures induced by kainic acid. Brain Res. 673:1995;297-303.
289. Rinaudo M. S., Su K., Falk L. A., Haldar S., Mufson R. A. Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. Blood. 86:1995;80-88.
290. Ripa S., Ripa R. Zinc and immune function. Minerva Med. 86:1995;315-318.
291. Rogers J. M., Taubeneck W. M., Daston G. P., Sulik K. K., Zucker R. M., Elstein K. H., Jankowski M. A., Keen C. L. Zinc deficiency causes apoptosis but not cell cycle alterations in organogenesis-stage rat embryos: Effect of varying duration of deficiency. Teratology. 52:1995;149-159.
292. Roher A. E., Kasunic T. C., Woods A. S., Cotter R. J., Ball M. J., Fridman R. Proteolysis of Aβ peptide from Alzheimer's disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 205:1994;1755-1761.
293. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X., Rahmani Z., Krizus A., Mckenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Van den Bergh R., Hung W. Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., Brown R. H. J. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
294. Rothwell N. J., Hopkins S. J. Cytokines and the nervous system. II. Actions and mechanisms of action. Trends Neurosci. 18:1995;130-136.
295. Rubin E. H. Psychopathology of senile dementia of the Alzheimer type. Wurtman R. J., Corkin S., Growdon J. H., Ritter-Walker E. Advances in Neurology. 1990;53-59 Raven Press, New York.
296. Rubin H., Koide T. Stimulation of DNA synthesis and 2-deoxy-D. J. Cell. Physiol. 81:1973;387-396.
297. St. George-Hyslop P. H., Tanzi R. E., Polinsky R. J., Haines J. L., Nee L., Watkins P. C., Myers R. H., Feldman R. G., Pollen D., Drachman D., Growdon J., Bruni A., Foncin J. F., Salmon D., Frommelt P., Amaducci L., Sorbi S., Piacentini S., Stewart G. D., Hobbs W. J., Conneally P. M., Gusella J. F. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 235:1987;885-890.
298. Samudralwar D. L., Diprete C. C., Ni B. F., Ehmann W. D., Markesbery W. R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130:1995;139-145.
299. Sato M., Bremner I. Oxygen free radicals and metallothionein. Free Radicals Biol. Med. 14:1993;325-337.
300. Sato M., Sasaki M., Oguro T., Kuroiwa Y., Yoshida T. Induction of metallothionein synthesis by glutathione depletion after trans- and cis-stilbene oxide administration in rats. Chem. Biol. Int. 98:1995;15-25.
301. Sato S. M., Frazier J. M., Goldberg A. M. The distribution and binding of zinc in the hippocampus. J. Neurosci. 4:1984;1662-1670.
302. Schafer B. W., Heizmann C. W. The S-100 family of EF-Hand calcium-binding proteins: Functions and pathology. Trends Biochem. Sci. 21:1996;134-140.
303. Scharfman H. E., Schwartzkroin P. A. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science. 246:1989;257-260.
304. Schwabe J. W. R., Klug A. Zinc mining for protein domains. Struct. Biol. 1:1996;345-349.
305. Selinfreund R. H., Barger S. W., Pledger W. J., Van Eldik L. J. Neurotrophic protein S-100β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. USA. 88:1991;3554-3558.
306. Selkoe D. J., Podlisny M. B., Gronbeck A., Mammen A., Kosik K. S. Molecular relation of amyloid filaments and paired helical filaments in alzheimer's disease. Wurtman R. J., Corkin S., Growdon J. H., Ritter-Walker E. Advances in Neurology. 1990;171-179 Raven Press, New York.
307. Shang Z., Liao Y. D., Wu F. Y. H., Wu C. W. Zinc release fromXenopus. Biochem. 28:1989;9790-9795.
308. Sheng J. G., Mrak R. E., Rovnaghi C. R., Kozlowska E., Van Eldik L. J., Griffin W. S. T. Human brain S-100β and S-100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease. Neurobiol. Aging. 17:1996;359-363.
309. Sherrington R., Rogaev E. I., Liang Y., Rogaev E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J. F., Bruni A. C., Montesi M. P., Sorbi S., Rainero I., Pinessi L., Polinsky R. J., Wasco W., Da Silva H. A. R., Haines J. L., Pericak-Vance M. A., Tanzi R. E., Roses A. D., Fraser P. E., Rommens J. M., St. George-Hyslop P. H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;755-760.
310. Shimizu T., Kubota M., Tanizawa A., Sano H., Kasai Y., Hashimoto H., Akiyama Y., Mikawa H. Inhibition of both etoposide-induced DNA fragmentation and activation of poly(ADP-ribose) synthesis by zinc ion. Biochem. Biophys. Res. Commun. 169:1990;1172-1177.
311. Shiraga H., Pfeiffer R. F., Ebadi M. The effects of 6-hydroxydopamine and oxidative stress on the level of brain metallothionein. Neurochem. Int. 23:1993;561-566.
312. Shiraishi K., Nakazawa S., Ito H. Zinc enhances kainate neurotoxicity in the rat brain. Neurol. Res. 15:1993;113-116.
313. Sillevis-Smitt P. A. E., Blaauwgeers H. G. T., Troost D., Vianney de Jong J. M. B. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 144:1992a;107-110.
314. Sillevis-Smitt P. A. E., Mulder T. P. J., Verspaget H. W., Blaauwgeers H. G. T., Troost D., Vianney de Jong J. M. B. Metallothionein in amyotrophic lateral sclerosis. Biol. Signals. 3:1994;193-197.
315. Sillevis-Smitt P. A. E., van Beek H., Baars A. J., Troost D., Louwerse E. S., Krops-Hermus A. C. M., de Wolff F. A., Vianney de Jong J. M. B. Increased metallothionein in the liver and kidney of patients with amyotrophic lateral sclerosis. Arch. Neurol. 49:1992b;721-724.
316. Simonian N. A., Getz R. L., Leveque J. C., Konrad C., Coyle J. T. Kainate induces apoptosis in neurons. Neuroscience. 74:1996;675-683.
317. Simons T. J. B. Intracellular free zinc and zinc buffering in human red blood cells. J. Membrane Biol. 123:1991;63-71.
318. Skulachev V. P., Chistyakov V. V., Jasaitis A. A., Smirnova E. G. Inhibition of the respiratory chain by zinc ions. Biochem. Biophys. Res. Commun. 26:1967;1-6.
319. Slomianka L. Neurons of origin of zinc-containing pathways and the distribution of zinc-containing boutons in the hippocampal region of the rat. Neuroscience. 48:1992;325-352.
320. Slomianka L., Danscher G., Frederickson C. J. Labeling of the neurons of origin of zinc-containing pathways by intraperitoneal injections of sodium selenite. Neuroscience. 38:1990;843-854.
321. Sloviter R. A selective loss of hippocampal mossy fiber Timm stain accompanies granule cell seizure activity induced by perforant path stimulation. Brain Res. 330:1985;150-153.
322. Sloviter R. S. A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res. Bull. 8:1982;771-774.
323. A. J. Physiol. 447:1992;587-625.
324. Smart T. G., Xie X., Krishek B. J. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog. Neurobiol. 42:1994;393-441.
325. Sofic E., Lange K. W., Jellinger K., Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142:1992;128-130.
326. Staal F. J. T., Ela S. W., Roederer M., Anderson M. T., Herzenberg L. A., Herzenberg L. A. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 339:1992;909-912.
327. Stanley L. C., Mrak R. E., Woody R. C., Perrot L. J., Zhang S. X., Marshak D. R., Nelson S. J., Griffin W. S. T. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53:1994;231-238.
328. Stengaard-Pedersen K., Fredens K., Larsson L. I. Comparative localization of enkephalin and cholecystokinin immunoreactivities and heavy metals in the hippocampus. Brain Res. 273:1983;81-96.
329. Stennard F. A., Holloway A. F., Hamilton J., West A. K. Characterisation of six additional human metallothionein genes. Biochim. Biophys. Acta. 1218:1994;357-365.
330. Stewart G. R., Frederickson C. J., Howell G. A., Gage F. H. Cholinergic denervation-induced increase of chelatable zinc in mossy-fiber region of the hippocampal formation. Brain Res. 290:1984;43-51.
331. Storm-Mathisen J., Ottersen O. P. Immunocytochemistry of glutamate at the synaptic level. J. Histochem. Cytochem. 38:1990;1733-1743.
332. Su J. H., Anderson A. J., Cummings B. J., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
333. Summers M. F., South T. L., Kim B., Hare D. R. High resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry approach. Biochem. 29:1990;329-340.
334. Sunderman F. W. J. The influence of zinc on apoptosis. Ann. Clin. Lab. Sci. 25:1995;134-142.
335. Sundstrom L. E., Mitchell J., Wheal H. V. Bilateral reorganization of mossy fibers in the rat hippocampus after a unilateral intracerebroventricular kainic acid injection. Brain Res. 609:1993;321-326.
336. Sutula T., Cascino G., Cavazos J., Parada I., Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26:1989;321-330.
337. Szabo C., Zingarelli B., O'Connor M., Salzman A. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. USA. 93:1996;1753-1758.
338. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A. P., St. George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
339. Taubeneck M. W., Daston G. P., Rogers J. M., Gershwin M. E., Ansari A., Keen C. L. Tumor necrosis factor-α alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J. Nutrition. 125:1995;908-919.
340. 4+8+IoIo. J. Cell. Physiol. 164:1995;259-270.
341. Terse P. S., Komiskey H. L. Modulation of a competitiveND. Brain Res. 744:1997;347-350.
342. Theoret Y., Earnhardt T. S., Bouldin T. W., Krigman M. R. The neurotoxicity of intrahippocampal kainic acid injection in rats is not accompanied by a reduction of Timm stain. Brain Res. 449:1988;341-346.
343. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
344. Thompson C. M., Markesbery W. R., Ehmann W. D., Mao Y. X., Vance D. E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-7.
345. Thornalley P. J., Vasak M. Possible role for metallothionein in protection against radiation-induced oxidative stress: Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta. 827:1985;36-44.
346. Tjian R. Molecular machines that control genes. Sci. Am. 272:1995;38-45.
347. Tonder N., Johansen F. F., Frederickson C. J., Zimmer J., Diemer N. H. Possible role of zinc in the selective degeneration of dentate hilar neurons after cerebral ischemia in the adult rat. Neurosci. Lett. 109:1990;247-252.
348. Treves S., Trentini P. L., Ascanelli M., Bucci G., Di Virgilio F. Apoptosis is dependent on intracellular zinc and independent of intracellular calcium in lymphocytes. Exp. Cell Res. 211:1994;339-343.
349. Tsuji S., Kobayashi H., Uchida Y., Ihara Y., Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J. 11:1992;4843-4850.
350. Tummino P. J., Scholten J. D., Harvey P. J., Holler T. P., Maloney L., Gogliotti R., Domagala J., Hupe D. Thein vitro. Proc. Natl. Acad. Sci. USA. 93:1996;969-973.
351. B. Brain Res. 596:1992;30-34.
352. 2+in vitroin vivo. Neuron. 11:1993;221-235.
353. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:1991;337-347.
354. Vallee B. L. Zinc in biology and biochemistry. Spiro T. G. Zinc Enzymes. 1983;1-24 Wiley, New York.
355. Vallee B. L. The function of metallothionein. Neurochem. Int. 27:1995;23-33.
356. Vallee B. L., Coleman J. E., Auld D. S. Zinc fingers, zinc clusters, and zinc twists in DNA-binding protein domains. Proc. Natl. Acad. Sci. USA. 88:1991;999-1003.
357. Vallee B. L., Falchuk K. H. The biochemical basis of zinc physiology. Physiol. Rev. 73:1993;79-117.
358. Van Eldik L. J., Christie-Pope B., Bolin L. M., Shooter E. M., Whetsell W. O. J. Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 542:1991;280-285.
359. Van Eldik L. J., Griffin W. S. T. S-100β expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1223:1994;398-403.
360. Velasco I., Tapia R., Massieu L. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 44:1996;551-561.
361. Vener A. V., Aksenova M. V., Burbaeva G. S. Drastic reduction of the zinc- and magnesium-stimulated protein tyrosine kinase activities in Alzheimer's disease hippocampus. FEBS Lett. 328:1993;6-8.
362. Vepachedu V. S. K. R., Mohan P. M. Efflux is a mechanism for zinc resistance inNeurospora crassa. Biochemistry. 35:1996;9301(76).
363. Walter R. M. Jr., Oster M. H., Lee T. J., Flynn N., Keen C. L. Zinc status in human immunodeficiency virus infection. Life Sci. 46:1990;1597-1600.
364. Wang H. Y., Pisano M. R., Friedman E. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol. Aging. 15:1994;293-298.
365. Wang T. L., Hackam A., Guggino W. B., Cutting G. R. A single histidine residue is essential for zinc inhibition of GABA ρ1 receptors. J. Neurosci. 15:1995;7684-7691.
366. Ward N. I., Mason J. A. Neutron activation analysis for identifying elemental status in Alzheimer's disease. J. Radioanal. Nucl. Chem. 113:1987;515-526.
367. Weiss J. H., Hartley D. M., Koh J. Y., Choi D. W. AMPA receptor activation potentiates zinc neurotoxicity. Neuron. 10:1993;43-49.
368. Wensink J., Lenglet W. J. M., Vis R. D., Van den Hamer C. J. A. The effect of dietary zinc deficiency on the mossy fiber zinc content of the rat hippocampus. Histochemistry. 87:1987;65-69.
369. Wensink J., Molenaar A. J., Woroniecka U. D., Van den Hamer C. J. A. Zinc uptake into synaptosomes. J. Neurochem. 50:1988;782-789.
370. Wenstrup D., Ehmann W. D., Markesbery W. R. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res. 533:1990;125-131.
371. A. NeuroReport. 6:1995;461-464.
372. Whitemore P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
373. Williams R. J. P. An introduction to the biochemistry of zinc. Mills C. F. Zinc in Human Biology. 1989;15-31 Springer-Verlag, London.
374. Williamson A., Spencer D. Zinc reduces dentate granule cell hyperexcitability in epileptic humans. NeuroReport. 6:1995;1562-1564.
375. Willson R. L. Zinc and iron in free radical pathology and cellular control. Mills C. F. Zinc in Human Biology. 1989;147-172 Springer-Verlag, London.
376. Wurtman R. J., Blusztajn J. K., Ulus I. H., Coviella I. L. G., Buyukuysal R. L., Growdon J. H., Slack B. E. Choline metabolism in cholinergic neurons: Implications for the pathogenesis of neurodegenerative diseases. Wurtman R. J., Corkin S., Growdon J. H., Ritter-Walker E. Advances in Neurology. 1990;117-125 Raven Press, New York.
377. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980.
378. Xie X., Gerbert U., Gahwiler B. H., Smart T. G. Interaction of zinc with ionotropic and metabotropic glutamate receptors in rat hippocampal slices. Neurosci. Lett. 159:1993;46-50.
379. Xu J., Xu Y., Nguyen Q., Novikoff P. M., Czaja M. J. Induction of hepatoma cell apoptosis by c-myc requires zinc and occurs in the absence of DNA fragmentation. Am. J. Physiol. 270:1996;G60-G70.
380. Yang J. P., Merin J. P., Nakano T., Kato T., Kitade Y., Okamoto T. Inhibition of DNA-binding activity of NF-κB by gold compoundsin vitro. FEBS Lett. 361:1995;89-96.
381. Yang Q., Hamberger A., Wang S., Haglid K. G. Appearance of neuronal S-100β during development of the rat brain. Dev. Brain Res. 91:1996;181-189.
382. Yao J., Kitt C., Reeves R. H. Chronic elevation of S-100β protein does not alter APP mRNA expression or promote β-amyloid deposition in the brains of aging transgenic mice. Brain Res. 702:1995;32-36.
383. Yasui M., Ota K., Garruto R. M. Concentrations of zinc and iron in the brains of Guamanian patients with amyotrophic lateral sclerosis and parkinsonism-dementia. Neurotoxicol. 14:1993;445-450.
384. m. Proc. Natl. Acad. Sci. USA. 93:1996;5709-5714.
385. 2+2+. NeuroReport. 6:1995;2553-2556.
386. Yokoyama M., Koh J., Choi D. W. Brief exposure to zinc is toxic to cortical neurons. Neurosci. Lett. 71:1986;351-355.
387. Yu C., Crutcher K. A. Nerve growth factor immunoreactivity and sympathetic sprouting in the rat hippocampal formation. Brain Res. 672:1995;55-67.
388. Yurchenco P. D., Schittny J. C. Molecular architecture of basement membranes. FASEB J. 4:1990;1577-1590.
389. Zabel U., Schreck R., Baeuerle P. A. DNA binding of purified transcription factor NF-κB. J. Biol. Chem. 266:1991;252-260.
390. Zahradka P., Ebisuzaki K. Poly(ADP-ribose) polymerase is a zinc metalloenzyme. Eur. J. Biochem. 142:1984;503-509.
391. Zalewski P. D., Forbes I. J., Betts W. H. Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin [(2-methyl-8-p. Biochem. J. 296:1993;403-408.
392. 2+. Biochem. Int. 24:1991;1103-1110.
393. Zalewski P. D., Forbes I. J., Giannakis C., Cowled P. A., Betts W. H. Synergy between zinc and phorbol ester in translocation of protein kinase C to cytoskeleton. FEBS Lett. 273:1990;131-134.
394. Zalewski P. D., Forbes I. J., Seamark R. F., Borlinghaus R., Betts W. H., Lincoln S. F., Ward A. D. Flux of intracellular labile zinc during apoptosis (gene-directed cell death) revealed by a specific chemical probe, Zinquin. Chem. Biol. 1:1994;153-161.
395. Zeng J., Heuchel R., Schaffner W., Kagi J. H. R. Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1. FEBS Lett. 279:1991a;310-312.
396. Zeng J., Vallee B. L., Kagi J. H. R. Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc. Natl. Acad. Sci. USA. 88:1991b;9984-9988.
397. 2+2+. J. Biol. Chem. 265:1990;2184-2189.
398. Zhao H., Eide D. The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitation. Proc. Natl. Acad. Sci. USA. 93:1996;2454-2458.